Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.617.1 (Kappa)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.46.5 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.16 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.5 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.34.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.2.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.9.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.469NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.80 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.8 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.128 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.220NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.438NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.1.257NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.5.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.323NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.105 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.9 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.398NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.94 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.164NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.275NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.419NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.151NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used